Abstract:BACKGROUND:Glycogen synthase kinase-3 (GSK-3) plays an important role in human cancer. The aim of this study is to evaluate the clinicopathological significance of expression of GSK-3α/β and pGSK-3α/β(Tyr279/216) in patients with epithelial ovarian cancer and to investigate whether GSK-3 inhibition can influence cell viability and tumor growth of ovarian cancer. METHODS:Immunohistochemistry was used to examine expression of GSK-3α/β and pGSK-3α/β(Tyr279/216) in 71 human epithelial ovarian cancer tissues and correlations between protein expression, and clinicopathological factors were analyzed. Cell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay following exposure of ovarian carcinoma cells to pharmacological inhibitors of GSK-3 or GSK-3 small interfering RNA. In vivo validation of tumor growth inhibition was performed with xenograft mice. RESULTS:The expression levels of GSK-3α/β and pGSK-3α/β(Tyr279/216) in ovarian cancers were significantly higher than those in benign tumors. High expression of GSK-3α/β was more likely to be found in patients with advanced International Federation of Gynecology and Obstetrics (FIGO) stages and high serum cancer antigen 125. Higher expression of pGSK-3α/β(Tyr279/216) was associated with advanced FIGO stages, residual tumor mass, high serum cancer antigen 125, and poor chemoresponse. Worse overall survival was revealed by Kaplan-Meier survival curves in patients with high expression of GSK-3α/β or pGSK-3α/β(Tyr279/216). Multivariate analysis indicated that FIGO stage, GSK-3α/β expression, and pGSK-3α/β(Tyr279/216) expression were independent prognostic factors for overall survival. GSK-3 inhibition by lithium chloride, 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), or GSK-3 small interfering RNA can decrease viability of SKOV3 and SKOV3-TR30 ovarian cancer cells. Additionally, lithium chloride-treated SKOV3 xenograft mice had a significant reduction in tumor growth compared with control-treated animals. CONCLUSION:Our findings suggest that overexpression and aberrant activation of GSK-3 may contribute to progression and poor prognosis in ovarian cancer. Inhibition of GSK-3 may be a potential therapy for ovarian cancer.

Switch of the Ovarian Cancer Cell to a Calcifying Phenotype in the Calcification of Ovarian Cancer

Conversion of Peripheral CD4+ CD25- Naive T Cells to CD4+ CD25+ Regulatory T Cells by Ovarian Carcinoma Cell Supernatants

Anti-tumor Effect and Its Antigenic Specificity of Cytotoxicity T Lymphocytes Induced by SKOV3 Ovarian Carcinoma Cell Line Freeze-thaw Antigen

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer.

Ovarian Cancer Cells Induce Peripheral Mature Dendritic Cells to Differentiate into Macrophagelike Cells in Vitro

Ovarian caremoma cell supernatants inhibit proliferation and IL-2R expression of CD8+ T cell

Inward Outward Signaling in Ovarian Cancer: Morpho-Phospho-Proteomic Profiling Upon Application of Hypoxia and Shear Stress Characterizes the Adaptive Plasticity of OVCAR-3 and SKOV-3 Cells

Apoptotic SKOV3 Cells Stimulate M0 Macrophages to Differentiate into M2 Macrophages and Promote Theproliferation and Migration of Ovarian Cancercells by Activating the ERK Signaling Pathway

[Biologic Characteristics of Intraperitoneal Transplantation Model of Human Ovarian Carcinoma in Severe Combined Immunodeficiency Mice].

Isolation and culture of cancer stem cells from ovarian cancer tissues and malignant ascites

Plasticity of Ovarian Cancer Cell SKOV3ip and Vasculogenic Mimicry in Vivo

Engineering Chemotherapeutic-Augmented Calcium Phosphate Nanoparticles for Treatment of Intraperitoneal Disseminated Ovarian Cancer

Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer

Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer

H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology

Calcification‐Based Cancer Diagnosis and Therapy

[Experimental Study on Resistance to Cisplatin and Taxol in Human Ovarian Cancer SKOV3ip1 Multicellular Aggregates].

[Study of growth, invasion and metastasis on ovarian epithelial cancer cell line with CCL18 over-expression by mediated in vitro]

LC-MS/MS Analysis of Ovarian Cancer Metastasis-Related Proteins Using a Nude Mouse Model: 14-3-3 Zeta As a Candidate Biomarker.

Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology

1α,25(OH)2D3 Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial–Mesenchymal Transition